USA - NASDAQ:CRGX - US14179K1016 - Common Stock
ChartMill assigns a Buy % Consensus number of 49% to CRGX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-08 | Jefferies | Maintains | Hold -> Hold |
| 2025-01-30 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2025-01-30 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-01-30 | Truist Securities | Downgrade | Buy -> Hold |
| 2025-01-30 | JP Morgan | Downgrade | Overweight -> Underweight |
| 2025-01-30 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-01-30 | Jefferies | Downgrade | Buy -> Hold |
| 2025-01-30 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-26 | William Blair | Initiate | Outperform |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Initiate | Buy |
| 2024-07-08 | Chardan Capital | Initiate | Buy |
| 2024-06-27 | Piper Sandler | Initiate | Overweight |
| 2024-05-16 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-12-05 | TD Cowen | Initiate | Outperform |
| 2023-12-05 | Truist Securities | Initiate | Buy |
| 2023-12-05 | JP Morgan | Initiate | Overweight |
| 2023-12-05 | Jefferies | Initiate | Buy |
11 analysts have analysed CRGX and the average price target is 5.61 USD. This implies a price increase of 25.5% is expected in the next year compared to the current price of 4.47.
The consensus rating for CARGO THERAPEUTICS INC (CRGX) is 49.0909 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering CARGO THERAPEUTICS INC (CRGX) is 11.